Joint Filing AgreementJoint Filing Agreement • February 14th, 2018 • ForArgos B.V. • Pharmaceutical preparations
In accordance with Rule 13d-1(f) under the Securities and Exchange Act of 1934, the persons or entities named below agree to the joint filing on behalf of each of them of a statement on Schedule 13D (including amendments thereto) with respect to the Shares of the Issuer and further agree that this joint filing agreement be included as an exhibit to this Schedule 13D. In evidence thereof, the undersigned, being duly authorized, have executed this Joint Filing Agreement as of February 14, 2018.
Shareholders’ Agreement January 27, 2016 ForArgos B.V. by and among Coöperatieve AAC LS U.A. and Forbion Co-Investment II Coöperatief U.A. and Forbion CF II Co-Invest I Coöperatief U.A.ForArgos B.V. • February 14th, 2018 • Pharmaceutical preparations
FORARGOS B.V. (“ForArgos”) is a private company with limited liability incorporated under the laws of the Netherlands (besloten vennootschap met beperkte aansprakelijkheid) on January 27, 2016. ForArgos has its official seat in Naarden and its registered office at Gooimeer 2-35, 1411 DC Naarden, The Netherlands. ForArgos is recorded at the trade registry of the Chamber of Commerce under file number: 65192125.
